Drugs - Real World Outcomes

eISSN: 2198-9788pISSN: 2199-1154
JournalOpen Access

Journal formatting to fit the target journal guidelines

Experts ensure all elements of your paper match journal formatting guidelines to improve publication success rate!

Key Metrics

CiteScore
2.7
H-Index
19
SJR
Q2Pharmacology (medical)
SNIP
0.87

Journal Specifications

Overview
  • Publisher
    SPRINGERNATURE
  • Language
    English
  • Frequency
    Quarterly
  • Article Processing Charges
    EUR 2190 | USD 2690 | GBP 1890
  • Publication Time
    8
  • Editorial Review Process
    Anonymous peer review
General Details
Publication Details
Editorial Review Detail
Information for authors
View less

Ready to spotlight your research findings?

Impress peers and journals alike with a concise, visual summary of your work.

Meets Top Publisher Standards: Essential for leading journals like Elsevier.
Enhances Engagement: Research papers with graphical abstracts receive 3X more downloads and 8X more shares.
Tailored Just for You: We’ll create a custom graphical abstract based on your manuscript—no sketches needed.
Learn more 3000+ graphical abstracts produced with 4.8/5 customer rating

Topics Covered

Blood pressure
Intellectual disability
Multiple sclerosis
Observational study
Rapid infusion
Polypharmacy
Diclofenac
Epidermal growth factor receptor
Systematic review
Antidepressant
Psoriatic arthritis
Potentially Inappropriate Medications
Daratumumab
Osteomyelitis
Cohort study
Adult patients
Body mass index
Intensive care unit
QT interval
Adjuvant therapy

Recently Published Papers

Year-wise Publication

FAQs

Since when has Drugs - Real World Outcomes been publishing? Faqs

The Drugs - Real World Outcomes has been publishing since 2014 till date.

How frequently is the Drugs - Real World Outcomes published? Faqs

Drugs - Real World Outcomes is published Quarterly.

What is the H-index. SNIP score, Citescore and SJR of Drugs - Real World Outcomes? Faqs

Drugs - Real World Outcomes has a H-index score of 19, Citescore of 2.7, SNIP score of 0.87, & SJR of Q2

Who is the publisher of Drugs - Real World Outcomes? Faqs

The publisher of Drugs - Real World Outcomes is SPRINGERNATURE.

How can I view the journal metrics of Drugs - Real World Outcomes on editage? Faqs

For the Drugs - Real World Outcomes metrics, please refer to the section above on the page.

What is the eISSN and pISSN number of Drugs - Real World Outcomes? Faqs

The eISSN number is 2198-9788 and pISSN number is 2199-1154 for Drugs - Real World Outcomes.

What is the focus of this journal? Faqs

The journal covers a wide range of topics inlcuding Blood pressure, Intellectual disability, Multiple sclerosis, Observational study, Rapid infusion, Polypharmacy, Diclofenac, Epidermal growth factor receptor, Systematic review, Antidepressant, Psoriatic arthritis, Potentially Inappropriate Medications, Daratumumab, Osteomyelitis, Cohort study, Adult patients, Body mass index, Intensive care unit, QT interval, Adjuvant therapy.

Why is it important to find the right journal for my research? Faqs

Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.

Can the choice of journal affect my academic career? Faqs

Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.

Is it advisable to target high-impact journals only? Faqs

While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.